USE OF POLYOXYETHYLENE-LIPID CONJUGATES AS LONG-CIRCULATING CARRIERS FOR DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS

被引:111
作者
TRUBETSKOY, VS [1 ]
TORCHILIN, VP [1 ]
机构
[1] HARVARD UNIV,SCH MED,BOSTON,MA 02129
关键词
AMPHIPHILIC POLYMER; MICELLE; POLYETHYLENEOXIDE; DRUG CARRIER; LYMPHATIC DELIVERY;
D O I
10.1016/0169-409X(95)00032-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The utilization of micelle forming block-copolymers as long-circulating drug carriers for sparingly soluble or amphiphilic drugs or diagnostic agents is reviewed with the emphasis on the use of phosphatidylethanolamine-polyethyleneoxide (PE-PEO) conjugates as structural amphiphilic polymers for formulation of polymeric micelles. PE-PEO conjugates spontaneously form particles with average diameter 10-30 nm depending on the molecular weight of PEO block and which are stable upon dilution at ambient temperature. Topoisomerase II inhibitor ellipticine was shown to be successfully incorporated into PE-PEO (5 kDa) conjugate micelles in vitro. Percutaneous lymphatic delivery of amphiphilic diagnostic agents incorporated into PE-PEO micelles was demonstrated using magnetic resonance imaging and gamma-scintigraphy. For water-soluble low molecular weight drugs one can expect hydrophobic prodrug approach to be most suitable for use with this drug delivery system.
引用
收藏
页码:311 / 320
页数:10
相关论文
共 33 条
  • [1] LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES
    ALLEN, TM
    HANSEN, C
    RUTLEDGE, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) : 27 - 35
  • [2] SPECIFIC TARGETING WITH POLY(ETHYLENE GLYCOL)-MODIFIED LIPOSOMES - COUPLING OF HOMING DEVICES TO THE ENDS OF THE POLYMERIC CHAINS COMBINES EFFECTIVE TARGET BINDING WITH LONG CIRCULATION TIMES
    BLUME, G
    CEVC, G
    CROMMELIN, MDJA
    BAKKERWOUDENBERG, IAJM
    KLUFT, C
    STORM, G
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1149 (01) : 180 - 184
  • [3] CHARMAN WN, 1992, LYMPHATIC TRANSPORT, P114
  • [4] MICROSPHERES FOR TARGETING DRUGS TO SPECIFIC BODY SITES
    DAVIS, SS
    ILLUM, L
    MOGHIMI, SM
    DAVIES, MC
    PORTER, CJH
    MUIR, IS
    BRINDLEY, A
    CHRISTY, NM
    NORMAN, ME
    WILLIAMS, P
    DUNN, SE
    [J]. JOURNAL OF CONTROLLED RELEASE, 1993, 24 (1-3) : 157 - 163
  • [5] DUNCAN R, 1992, ANTI-CANCER DRUG, V6, P175
  • [6] FORMATION AND PROPERTIES OF 1000-A-DIAMETER, SINGLE-BILAYER PHOSPHOLIPID VESICLES
    ENOCH, HG
    STRITTMATTER, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (01) : 145 - 149
  • [7] A LIPOSOMAL MRI CONTRAST AGENT - PHOSPHATIDYLETHANOLAMINE DTPA
    GRANT, CWM
    KARLIK, S
    FLORIO, E
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1989, 11 (02) : 236 - 243
  • [8] KABALKA G, 1989, MAGN RESON MED, V8, P89
  • [9] THE NEUROLEPTIC ACTIVITY OF HALOPERIDOL INCREASES AFTER ITS SOLUBILIZATION IN SURFACTANT MICELLES - MICELLES AS MICROCONTAINERS FOR DRUG TARGETING
    KABANOV, AV
    CHEKHONIN, VP
    ALAKHOV, VY
    BATRAKOVA, EV
    LEBEDEV, AS
    MELIKNUBAROV, NS
    ARZHAKOV, SA
    LEVASHOV, AV
    MOROZOV, GV
    SEVERIN, ES
    KABANOV, VA
    [J]. FEBS LETTERS, 1989, 258 (02) : 343 - 345
  • [10] AMPHIPATHIC POLYETHYLENEGLYCOLS EFFECTIVELY PROLONG THE CIRCULATION TIME OF LIPOSOMES
    KLIBANOV, AL
    MARUYAMA, K
    TORCHILIN, VP
    HUANG, L
    [J]. FEBS LETTERS, 1990, 268 (01) : 235 - 237